All Industries

EcoAI Coin: A Sustainable Coin For Planet Earth

Benzinga

By Austin DeNoce, Benzinga EcoAI Coin is a cryptocurrency project designed to merge digital currency and environmental sustainability. At its core, EcoAI Coin utilizes blockchain technology and artificial intelligence to foster eco-friendly practices within the crypto community. The primary mission of EcoAI Coin is threefold: to elevate environmental awareness in the cryptocurrency space, to create incentives for sustainable actions by rewarding individuals and organizations for adopting green practices and to foster accountability by implementing transparent reporting of energy consumption and environmental impact. By integrating these principles, EcoAI Coin aims to make sustainability a fundamental part of the digital currency ecosystem, which has been criticized for its heavy energy consumption. EcoAI Coin Ecosystem The EcoAI Coin ecosystem is built on the Ethereum blockchain – leveraging its secure, well-established platform to create a sustainable cryptocurrency ecosystem. Key partners like Cointelegraph, DailyCoin and CryptoNews are already supporting the project, underscoring its credibility and growing impact. The ecosystem features smart contracts that automate operations like token distribution, incentive mechanisms and governance and transactions within the eco-friendly marketplace. These self-executing contracts ensure transparency, security and adherence to predefined rules. A standout feature of the EcoAI Coin ecosystem is the Proof of Environmental Work mechanism. This model rewards participants for verifiable eco-friendly actions, such as reducing carbon emissions or utilizing renewable energy sources. By aligning the mining process with environmental sustainability, EcoAI Coin incentivizes greener practices across the crypto community. Artificial intelligence also plays a critical role – monitoring, verifying and reporting on the environmental impact of operations and participants' actions. AI algorithms analyze data to ensure accurate reward distribution based on sustainable practices, enhancing the efficiency and integrity of the incentive system. EcoAI Coin Roadmap EcoAI Coin has a detailed roadmap outlining its development and implementation strategy. The roadmap kicked off with the EcoAI Coin presale in Q1 2024, followed by the launch of the website, social media platforms and marketing efforts in Q2. In Q3, the company plans to establish partnerships and collaborations with environmental organizations and like-minded projects while developing incentive programs. The roadmap continues with the ICO launch and ecosystem expansion, including an airdrop to early adopters and carbon credit integration. Future plans involve expanding and scaling the ecosystem, enhancing its utility and extending its global reach. EcoAI Coin plans to introduce sustainability reports and establish more international partnerships to solidify its commitment to environmental sustainability. The upcoming EcoAI Coin wallet will provide a secure and user-friendly platform for managing digital assets that facilitates eco-conscious cryptocurrency transactions. EcoAI Coin Tokenomics EcoAI Coin's tokenomics are designed to support long-term growth and fair distribution. Here's how the tokens are allocated: Public Sale/DEX: 20% Ecosystem Reserve: 20% Community Incentive Rewards: 20% Partners & Collaborators: 10% Marketing: 10% Initial Early Investors: 10% Team: 5% Charity: 5% This strategy prioritizes public sales, ecosystem reserves and community incentives, aligning with EcoAI Coin's mission to promote environmental sustainability and encourage green practices. Additionally, allocations for partners, marketing, early investors, the team and charity help drive the project's growth and development. Pioneering A Greener Future EcoAI Coin is a pioneering project dedicated to integrating sustainability into the digital currency ecosystem. By leveraging blockchain technology and artificial intelligence, EcoAI Coin is taking a modern approach to promoting eco-friendly practices and fostering accountability within the crypto community. As the project progresses, EcoAI Coin expects to expand its reach and utility, driving global adoption and setting a new standard for sustainable cryptocurrencies that could help alter the impact on the planet for the better. Featured photo by Noah Buscher on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

July 29, 2024 08:45 AM Eastern Daylight Time

Image

Li-FT Power Cements Position In North America's Expanding Lithium Market With Strategic Canadian Projects

Benzinga

By Mangeet Kaur Bouns, Benzinga The lithium market is experiencing unprecedented growth, fueled primarily by the rapid expansion of the electric vehicle (EV) industry, which heavily relies on lithium-ion batteries for their superior energy density and longevity. Additionally, the surge in renewable energy storage systems, consumer electronics, technological innovations and supportive government policies are significantly broadening the lithium market. This surge is creating potential opportunities for companies engaged in acquiring, exploring, and developing lithium projects. Li-FT Power Ltd. (OTC: LIFFF) is one such company making strides in this growing sector. Focused on lithium pegmatite projects in Canada, Li-FT is strategically positioning itself to benefit from the growing demand for lithium, which is essential for the ongoing EV revolution and the global transition to clean energy. The company's diverse project portfolio and forward-thinking initiatives underscore its potential to be a pivotal player in the lithium market. North America's Lithium Market: Driving The Future Of Clean Energy The lithium sector in the U.S. and Canada could be poised for substantial growth in 2024 and beyond despite recent global pricing and demand challenges. The U.S. saw a remarkable increase in lithium-ion battery imports in the first quarter of 2023, reaching 235,386 metric tons, marking a 66% rise from the previous year. This surge underscores the escalating demand for lithium, driven by the expanding EV market and the clean energy transition. In addition to increasing imports, America also witnessed a notable rise in the construction of lithium-ion battery factories, fueled by manufacturing tax incentives from the Inflation Reduction Act of 2022. In Canada, particularly Quebec, there is a strong push to develop a fully integrated supply chain from lithium mining to EV manufacturing. With the world's sixth-largest lithium reserves, Canada is focusing on harnessing its 930,000 tonnes of lithium to support the growing market. Amid ongoing geopolitical uncertainties and the aftermath of the pandemic, companies in the U.S. and Canada are revisiting undeveloped lithium assets, accelerating existing projects and exploring new opportunities. Favorable government policies promoting clean energy and regional battery supply chains are driving this renewed focus, with significant construction activities anticipated across various states and provinces in the coming years. According to the S&P Global Commodity report, lithium-ion battery capacity is projected to more than double by 2030, reaching 6.5 terawatt-hours (TWh). Additionally, the demand for lithium-powered EV batteries is anticipated to grow annually by over 22%, with the electric vehicle transport sector expected to account for 93% of the market share by 2030. Li-FT Power, which operates five high-yield lithium pegmatite projects across three regions safe and mining-friendly jurisdictions in Canada, seems poised to capitalize on the rapidly expanding lithium market and contribute to the future of clean energy. Li-FT Power's Flagship Yellowknife Lithium Project At the heart of Li-FT Power’s portfolio is the Yellowknife Lithium Project in the Northwest Territories, which stands out as a potentially significant source of hard rock lithium in North America. This project encompasses 13 lithium pegmatite systems, with grades averaging between 1.0% and 1.2% Li2O over widths of 10 to 30 meters and strike lengths up to 1,800 meters. These systems are predominantly exposed at the surface, making them easily visible from satellite imagery. As of April 2024, Li-FT had completed 50,000 meters of resource development drilling, significantly advancing the project toward a maiden resource estimate. Recent drilling results have been promising, with notable intersections such as 35 meters at 1.32% Li2O at the Shorty pegmatite and 28 meters at 1.7005% Li2O at the BIG East pegmatite, underscoring the project's potential to yield substantial lithium resources. Exploration Projects In Quebec: Rupert, Pontax And Moyenne Li-FT’s portfolio extends beyond the Northwest Territories to Quebec, where it holds three early-stage exploration properties: the Rupert, Pontax and Moyenne projects. These projects are strategically positioned to tap into Quebec's rich lithium potential. The Rupert Project, spanning 141,572 hectares in the James Bay region, commenced initial drilling in March last year, with plans for 17 holes (5,000 meters) targeting lithium-bearing pegmatites under cover. The Pontax Project, covering 61,520 hectares, features the most extensive lithium anomaly in Li-FT’s Quebec portfolio and benefits from convenient highway access. Summer 2023 exploration activities revealed a significant 13 km by 6 km lithium anomaly at Pontax, with additional spodumene anomalies identified on the Rupert Property. CEO Francis MacDonald highlighted the potential for a large spodumene pegmatite dyke swarm in the Pontax area based on the anomaly's size and spodumene grain counts. The Moyenne Project, covering 25,145 hectares, is in an earlier exploration stage, with regional till sampling completed and further surface work planned. This 100% owned property is accessible by helicopter and holds promise for future exploration efforts. Cali Project: Exploring The Little Nahanni Pegmatite Group Adding further depth to Li-FT’s portfolio is the Cali Project, located within the Little Nahanni Pegmatite Group in the Northwest Territories near the Yukon border. Acquired in 2022 alongside the Yellowknife Project, the Cali Project features a spodumene pegmatite system with significant vertical and horizontal extents, outcropping over a 500-meter strike length and up to 100 meters in width. In 2023, Li-FT conducted a comprehensive soil geochemistry survey and mapping campaign at Cali, revealing that the spodumene pegmatite dyke swarm system exceeds initial expectations. Rock sampling and mapping efforts have shown high lithium grades, with 124 out of 163 grab samples returning grades exceeding 1.0% Li2O. These findings underscore the project's potential to become a significant lithium resource. Li-FT Power's Strategic Position In A Booming Market The North American lithium sector is undergoing a transformative period, driven by the accelerating demand for lithium-ion batteries, especially for electric vehicles. Government policies supporting clean energy and the establishment of regional battery supply chains are further bolstering this growth. Canada, particularly Quebec, is taking significant steps to develop a comprehensive supply chain from mining to EV production, underscoring the strategic importance of lithium in the global clean energy transition. Li-FT Power seems to be strategically positioned to capitalize on these trends. With its flagship Yellowknife Lithium Project and promising exploration projects in Quebec and the Northwest Territories, Li-FT is at the forefront of advancing lithium resources to meet the growing demand for EV batteries. As the company continues to make strides in its exploration and development activities, it stands out as a potential key player in the lithium sector, driving innovation and sustainability in the clean energy landscape. Featured photo by MiningWatch Portugal on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

July 29, 2024 08:35 AM Eastern Daylight Time

Image

Linqto’s Platform Provides Interested Investors With True Access To Pre-IPO Companies

Benzinga

By Kyle Anthony, Benzinga For most investors, investable assets include public equities, bonds, real estate and even precious metals, such as gold. However, even though they can be lucrative as early-stage investments, private equity investments are not considered part of the investment opportunity for most due to their high capital requirements and limited access. Linqto is looking to change the investment landscape for retail investors by making investing in private companies as easy and accessible as investing in the public stock market. In doing this, they are widening the investment opportunities available to investors, enabling them to become beneficial participants in the potentially phenomenal growth pre-Initial Public Offering (IPO) firms can experience, resulting in them garnering investment returns beyond what is usually attainable in public markets. Accessing Private Market Investment With Linqto With companies in recent times staying private for longer, the opportunity for retail investors to access companies reshaping industries, commerce and societal engagement is regularly decreasing as the leaders of these organizations opt to delay entering public markets. With the wellspring of capital available to these firms through angel investors, venture capital firms and private equity institutions, there is no sense of urgency or enthusiasm to become public entities. As such, the economic benefit that these firms derive from their business model benefits a select few. Linqto’s investment platform provides retail investors access to high-growth, technology-driven companies that the firm believes will go public or be acquired within 5 years. Linqto conducts in-depth due diligence on the firms it includes on its platform as it invests alongside its investors. By investing first and ensuring that Linqto has skin in the game, the firm can streamline the investment process, making it as easy as pointing and clicking to participate in the investment opportunities presented on their platform. Its focus is on mid-to-late-stage private companies within the technology industry, where selected firms must be generating a minimum revenue with institutional venture capital or private equity investor backing. Finally, Linqto’s fee structure is a true differentiator, as it is a zero-fee investment management platform. Given that Linqto purchases shares in large quantities from founders, employees and investors, it receives these shares at a negotiated price. Linqto can then make smaller quantities of its shareholdings available to investors at a reasonable markup, thus eliminating the need for further follow-on fees for the investor. Linqto’s Investment Platform versus Other Self-Directed Investment Platforms Linqto’s investment platform is solely dedicated to private, pre-IPO investing; once a company on its platform enters the public market, it will transfer the now-public, registered shares of stock into an investor’s brokerage account. The difference in Linqto’s value proposition is highlighted when contrasted against other self-directed investment platforms. Recently, Charles Schwab Corp. (NYSE: SCHW) announced it would launch a self-directed alternative investments platform for qualified individual investors with assets of more than $5 million. The platform will offer investors access to private equity, venture capital, private credit and long-short exchange funds. Linqto’s approach vastly differs from Charles Schwab's, as its initial minimum investment amount is just $2,500, with subsequent investment amounts being $5,000. Furthermore, Linqto’s platform provides investors access to full equity ownership in companies – not private equity funds. It is important to note that you must be an accredited investor to invest on the platform.* The difference is even more evident when contrasting Linqto with Robinhood (NASDAQ: HOOD), the popular commission-free stock trading and investing app. Robinhood allows users to invest in publicly traded investment offerings, not pre-IPO offerings. Though Robinhood does allow for ‘pre-IPO orders,’ this is not the same as investing in pre-IPO investments; it is merely Robinhood providing the convenience of entering investor orders before the morning of the IPO. They cannot execute an order until the stock begins officially trading publicly. Historically, investing in a private company required individuals to invest at least $100,000. Though firms such as Forge Global Holdings (NYSE: FRGE), EquityZen and HIIVE facilitate pre-IPO investing, Linqto says its fee structure is more advantageous to retail investors desiring access to private investment opportunities. Utilizing Linqto To Access Private Investment Opportunities For retail investors who have been unable to add non-public investments to their portfolio due to high minimum investments and restrictive fee structures, Linqto is revolutionizing the investment journey in the private market by making it affordable, accessible and easy. As companies remain private longer, attaining operational scale and achieving significant revenue growth year over year, their investors benefit from the phenomenal growth these firms may experience, resulting in them garnering investment returns far beyond what is usually attainable in public markets. Linqto desires to provide this opportunity to retail investors through their platform, broadening their investment opportunity set and giving them access to tremendous wealth generation. Click here to visit the Linqto website and begin your private investing journey. *In the United States, an accredited investor is someone who has earned $200,000 in gross income the last two years ($300,000 if filing with a spouse or partner), someone who has a net worth of $1,000,000 aside from their primary residence, or someone who holds a valid FINRA Series 7, 65, or 82 license. Featured photo by Joshua Mayo on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

July 29, 2024 08:30 AM Eastern Daylight Time

Image

AGC Biologics’ Seattle Site Achieves Successful Multi-Product Inspection by U.S. Food and Drug Administration for Biologics License Applications

AGC Biologics

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today that its Seattle Campus completed a new commercial milestone for regulatory compliance in 2024. The site supported a multi-product inspection in March 2024 with the Food and Drug Administration (FDA) to support Biologics License Applications (BLA) for new products seeking commercial approval in the U.S., two of which are now approved for commercial production at the facility. The two approved products include a fusion protein-based drug for treating bladder cancer and a monoclonal antibody (mAb) for treating macular degeneration. AGC Biologics Seattle predicts delivering multiple batches per year for the biopharma partners that received the approvals and accommodating increases in future demand. “This achievement is significant for this site, our team members and our partners in the pharmaceutical industry seeking to bring products from clinical stages to commercial approval,” notes Michael Tranmer, General Manager of AGC Biologics Seattle. “Inspections for multiple products at one time is not easy. This accomplishment is a true testament to our commitment to quality and regulatory compliance and helping developers reach their goals as fast and efficiently as possible.” This is the latest achievement for the Seattle-based CDMO manufacturing site, which has produced six commercial products for AGC Biologics. This includes three commercial approvals in the last two years. AGC Biologics Seattle is active in helping clients navigate clinical milestones, as well. The site team is working with several clinical-stage companies and predicts more commercial license application submissions in the coming 18 to 24 months. AGC Biologics runs multiple mammalian cGMP manufacturing lines and a variety of scales at its Seattle site. The campus serves as a center of excellence for formulation and employs the latest fed-batch and perfusion manufacturing processes. Over the last year, AGC Biologics Seattle has also expanded. This work includes a new microbial-based manufacturing line system and a state-of-the-art 67,000 sq. ft. GMP-compliant warehouse to further enhance the quality, efficiency and operational excellence of the site. To learn more about AGC Biologics’ protein biologics manufacturing site in Seattle, visit www.agcbio.com/facilities/seattle. For more information on the company’s end-to-end global CDMO services in the U.S., Europe, and Japan visit www.agcbio.com. About AGC Biologics: AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan. We currently employ more than 2,500 Team Members worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is a part of AGC Inc.’s Life Science Company. The Life Science company runs more than 10 global facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com. Contact Details Nick McDonald +1 425-419-3555 nmcdonald@agcbio.com Company Website https://www.agcbio.com/

July 29, 2024 05:30 AM Pacific Daylight Time

GCC Advisors Announces Strategic Initiatives to Enhance Global Business Expansion Services

Rev Up Marketers

GCC Advisors, led by seasoned industry experts Manuel Manzoni and Marco Scardeoni, is proud to announce a series of strategic initiatives aimed at bolstering support for businesses pursuing international expansion. With a commitment to transparency, integrity, and excellence, GCC Advisors is dedicated to providing businesses with the confidence and tools necessary to navigate the complexities of global markets successfully. A key aspect of these initiatives is enhancing transparency in client relationships. GCC Advisors places a strong emphasis on ensuring clients are well-informed at every stage of their international expansion journey. The firm’s approach includes detailed consultations, clear communication, and continuous support, fostering an environment of trust and confidence. This initiative aims to streamline the expansion process, providing businesses with the clarity needed to make informed decisions. Under the leadership of Manuel Manzoni and Marco Scardeoni, GCC Advisors upholds the highest standards of integrity. The firm adheres to stringent ethical standards, prioritizing honesty, fairness, and accountability in all client interactions. This commitment to integrity not only strengthens client relationships but also reinforces GCC Advisors' reputation as a reliable and credible partner in the industry. Photo Credit: Manuel Manzoni & Marco Scardeoni GCC Advisors is dedicated to delivering excellence in service offerings. The firm’s comprehensive services—from strategic planning to implementation—are designed to achieve superior results that exceed client expectations. This focus on high-quality service ensures that clients receive the best possible support for their international expansion efforts. Recognizing the challenges of entering foreign markets, GCC Advisors leverages its extensive expertise to guide clients through the complexities of international business. With a deep understanding of global market dynamics, GCC Advisors provides tailored solutions that address specific client needs, ensuring a smooth and successful expansion process. GCC Advisors adopts a personalized approach by developing customized strategies that align with each client’s unique objectives and challenges. This tailored methodology allows GCC Advisors to offer targeted solutions that drive success, enhancing client satisfaction and building long-term trust. To ensure continuity of core business operations during international expansion, GCC Advisors focuses on maximizing efficiency and minimizing disruption. The firm’s streamlined processes enable businesses to maintain operational stability while pursuing growth opportunities abroad. Fostering long-term partnerships is a key priority for GCC Advisors. Manuel Manzoni and Marco Scardeoni view each client engagement as a collaborative journey toward mutual success. By providing ongoing support and strategic guidance, GCC Advisors becomes a trusted advisor and partner, committed to helping businesses thrive in the global marketplace. GCC Advisors values client feedback as a critical component of continuous improvement. By actively seeking and incorporating client input, GCC Advisors ensures its services remain at the forefront of industry trends and best practices. This commitment to innovation drives ongoing enhancement of the firm’s value proposition. With these strategic initiatives, GCC Advisors reaffirms its dedication to supporting businesses in their global expansion endeavors. By maintaining a focus on transparency, integrity, and excellence, GCC Advisors provides clients with the assurance and expertise needed to succeed in international markets. For more information about GCC Advisors and their services, visit https://gcc-advisors.com/. About GCC Advisors GCC Advisors is a leading consultancy firm specializing in global business expansion services. With a team of experienced professionals, the company offers strategic planning, market analysis, and tailored solutions to help businesses successfully navigate international markets. Committed to excellence and integrity, GCC Advisors provides comprehensive support to ensure seamless expansion and long-term success for its clients. Contact Information: GCC Advisors GCC Advisors S.r.l. Via Papa Giovanni XXIII, 67 25015 Desenzano del Garda (BS), Lombardy, Italy Email: info@gccadvisorssrl.com Website: https://gcc-advisors.com/ Contact Person: Manuel & Marco Contact Details GCC Advisors Manuel & Marco info@gccadvisorssrl.com Company Website https://gcc-advisors.com/

July 29, 2024 07:43 AM Eastern Daylight Time

Image

News Release

KindlyMD, Inc. (NASDAQ: KDLY): Advancing the $11.6 Billion Medical Cannabis Market in Chronic Pain Treatment

RazorPitch KDLY

Amidst the ongoing opioid crisis, which has prompted increasing scrutiny of traditional pain treatments, there is a growing recognition of the need for comprehensive and effective approaches to pain relief. This shift is creating a market for innovative solutions that integrate conventional medical practices with alternative therapies, such as medical cannabis. As more patients and providers seek to navigate the complexities of pain management, the landscape is evolving rapidly, paving the way for new opportunities in healthcare delivery. KindlyMD, Inc. (NASDAQ: KDLY) has emerged as a pioneer in integrating traditional primary care with alternative pain management strategies. Founded on a patient-first philosophy, KindlyMD operates four centers, including the largest alternative pain treatment center in Utah. The company combines primary care, pain management, behavioral therapy, and alternative treatments, including medical cannabis recommendations, to offer comprehensive care and reduce opioid dependency. Financial Milestones and Market Presence KDLY announced the closing of its IPO of 1,240,910 units at $5.50 per unit, raising approximately $6.8 million in gross proceeds back in early June. This financial boost positions KindlyMD to execute its growth strategy effectively. Additionally, KindlyMD has made significant strides in becoming the first alternative medical treatment company in Utah to contract with the state's top insurance payors, including Select Health, Medicare, Medicaid, and Blue Cross Blue Shield, covering nearly 80% of Utah's population. "This is a major milestone for KindlyMD," said Tim Pickett, PA-C, founder and CEO of KindlyMD. "Now, the scope of services we provide at our Company-branded clinics, including behavioral healthcare and medical interventions incorporating alternative medicine, are covered by and reimbursable by the largest insurance providers across the state." Addressing the Opioid Crisis Provisional data from the CDC's National Center for Health Statistics indicates that in 2021, nearly 108,000 people died of drug overdose in the U.S., with over 80,000 of these deaths attributed to opioids. The government has responded with the largest opioid treatment grant funding ever. Despite widespread use of prescription medication among Americans aged 45-64, many of these prescriptions are insufficient and carry significant long-term side effects. KindlyMD is addressing this crisis head-on by offering non-opioid treatment options like medical cannabis, which have become more widespread in recent years. However, these options are often excluded from clinical recommendations and guidelines, creating an unmet need that KindlyMD aims to fill. To date, the company has seen over 60,000 patient visits in its clinics, providing comprehensive care plans that ensure safe use, appropriate dosing, and behavioral health support for those who need opioids. Strategic Collaborations and Community Outreach On June 10, KDLY announced a collaboration with Curaleaf Holdings, Inc., a leading international provider of cannabis products. The two companies are working together to provide educational resources on holistic pain management and treatment options, including medical cannabis. This partnership includes community care events throughout the summer, aiming to enhance patients understanding of holistic pain management "Our innovative collaboration with Curaleaf will provide more patients with access to pain management treatment options and alternative therapies," said Tim Pickett. "As the U.S. government moves toward rescheduling cannabis as a legitimate medicine, this collaboration will help more patients find sustainable, safer, and more affordable healthcare treatment options." KDLY recently submitted a comment to the U.S. Department of Justice regarding the proposed reclassification of cannabis from Schedule I to Schedule III of the Controlled Substances Act. This reclassification is expected to have several positive impacts on the medical cannabis industry, including reducing patient costs and enabling businesses to deduct standard operating expenses. "Reclassification underscores the continued relevance and importance of our integrated healthcare model," said Tim Pickett. "It will likely lead to increased access and utilization of medical cannabis among our patients, benefiting KindlyMD through improved patient outcomes, new educational opportunities, and enhanced financial stability." Federal Funding Initiatives KindlyMD's successful registration on SAM.gov, the official U.S. federal funding platform, marks a significant milestone for the company. This registration enables KindlyMD to obtain federal grants and contracts, including those with the Department of Veterans Affairs, to support its mission of providing comprehensive healthcare solutions. Following its registration, KindlyMD submitted its first grant application for the USDA Rural Utilities Service Distance Learning and Telemedicine Grant Program, seeking $1,000,000 to expand its Complete Care telehealth program in rural communities in Utah. This program aims to deliver effective healthcare through an interconnected network of telemedicine clinics, addressing the unique challenges faced by rural populations. Financial Performance For the quarter ended March 31, 2024, KDLY reported revenues of $829,029, a decrease compared to the previous year, primarily due to a shift towards insurance billing. However, the company began receiving reimbursements from insurance payors for the first time in its history during this period, amounting to $34,722. Operating expenses decreased by 21.9%, and the company reported a net loss per share decrease of 50%. The capital raised from the IPO will enable KindlyMD to invest in growth opportunities, including mergers and acquisitions of additional clinics in Utah. With over 16% of the medical cannabis patient population in Utah already under its care, KindlyMD is well-positioned to expand its reach and enhance patient outcomes. KindlyMD, Inc.'s (NASDAQ: KDLY) innovative approach and industry expertise position it uniquely to continue providing unique healthcare services. As the regulatory landscape evolves, KDLY remains a crucial partner for patients seeking alternative and integrative healthcare solutions, particularly in the ongoing battle against the opioid epidemic. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Cambridge Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700

July 29, 2024 06:00 AM Eastern Daylight Time

Text Patents a Method for Combining Asynchronous and Real-Time Communication

Text, Inc.

Text, a global leader in B2B text communication solutions, has secured its fifth patent in the United States. The patented "system and method" enables the seamless integration of asynchronous communication channels with real-time communication within a single platform. "Customers want to communicate with companies in various ways. Sometimes, an email or another method that allows the recipient to respond later is best, which is asynchronous communication. However, sometimes rapid, direct, real-time interaction is necessary. Our technology enables seamless integration of these communication types, providing real benefits for our clients: increased user satisfaction, faster issue resolution, and better management of existing information, " explains Konrad Kruk, Head of Widget and the patent's author. The patent granted by the United States Patent and Trademark Office (USPTO) describes a system and method that integrates asynchronous messaging with real-time communication, allowing smooth transitions between different communication modes within a single platform. The invention enables users to switch between messages (such as emails or SMS) and real-time interactions (such as voice or video calls) without leaving the communication platform or starting a new session. "This is our fifth patent, confirming our position as one of the technological innovators in the industry. We are especially proud because the secured solution introduces significant improvements in online communication, ensuring companies maintain uninterrupted and consistent communication with customers across various industries, " said Katarzyna Rogowska, head of Text's legal department. The key benefits of the newly patented solution for Text's clients and end-users include: - Improved communication efficiency: Combining asynchronous messaging with real-time communication on one platform reduces the need to switch between different communication tools, saving time and increasing productivity. - Enhanced user experience: Internet users communicating with companies via solutions like LiveChat can enjoy seamless communication, effortlessly transitioning between messaging and real-time conversations. This particularly benefits customer service, remote work, and collaborative projects. - Increased accessibility: The unified interface makes managing communications easier, ensuring that important messages and real-time interactions are never missed. This is particularly useful in environments where timely communication is critical. - Easier and more efficient record-keeping: The synchronization feature ensures that all communications are recorded, providing a reliable record of interactions. This can be crucial for legal, compliance, and reference purposes. - Scalability and flexibility: The system can be scaled to suit different organizational sizes and integrated with other systems, making it a flexible solution for various industries and applications. In summary, the invention registered by the USPTO enhances communication by combining the advantages of asynchronous messaging and real-time communication in one coherent system, offering increased efficiency, user experience, and accessibility for individuals and organizations. Operating in the “customer service” business, Text (formerly LiveChat) is one of the leaders in the global market for live chat solutions. Its LiveChat product supports companies in customer service, online sales support, and lead generation—allowing its partners to stay in touch with their customers anywhere and anytime. Text’s other products include ChatBot, HelpDesk, KnowledgeBase, and OpenWidget. LiveChat is used by over 37 thousand companies in 150 countries, the ChatBot product has over 2,800 customers in more than 30 countries, and the Helpdesk product has over 1,000 customers. Contact Details PR Team pr@text.com Company Website https://text.com/

July 29, 2024 05:34 AM Eastern Daylight Time

BestGrowthStocks.Com Issues a Comprehensive Analysis of Tivic Health Systems Potential Catalysts

Tivic Health Systems Inc.

NEW YORK, NY / NewsDirect / July 29, 2024 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive analysis on Tivic Health Systems Inc. a health tech company that develops and commercializes bioelectronic medicine. Tivic Health Systems Inc. (NASDAQ: TIVC) recently announced the expansion of its intellectual property portfolio with three new patents granted in the US and Europe. Best Growth Stocks full report breaks through the noise and offers an extensive comprehensive analysis of Tivic Health Systems operations, potential catalysts, pipeline, patents, share structure, recent news events, growth strategy, financials, chart support and resistance zones, and more. Access this full analysis free here: https://bestgrowthstocks.com/access-tivc-analysis/ Access the full analysis free here: https://bestgrowthstocks.com/access-tivc-analysis/ About Tivic Tivic is a commercial health tech company advancing the field of bioelectronic medicine. Tivic’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Tivic’s non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. Tivic’s first commercial product ClearUP is an FDA approved, award-winning, handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and is available through online retailers and commercial distributors. For more information visit http://tivichealth.com. About Best Growth Stocks Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions. Media Contact Best Growth Stocks Senior Editor: Steve Macalbry Editor@BestGrowthStocks.com Contact Details Best Growth Stocks Steve Macalbry Editor@bestgrowthstocks.com

July 29, 2024 04:25 AM Eastern Daylight Time

Image

Trust Stamp and Botdoc Forge Strategic Partnership to Enhance Automotive Security

T Stamp Inc

Trust Stamp President Andrew Gowasack and Karl Falk, CEO of Botdoc joined Steve Darling from Proactive to announce an exciting new partnership. The collaboration aims to integrate Trust Stamp’s low-code Orchestration Platform into Botdoc Connect product, enhancing Identity Verification and Know Your Customer processes. This integration will include document validation using the Driver License Data Verification System provided by the American Association of Motor Vehicle Administrators. Trust Stamp has obtained a license from AAMVA to access this system, ensuring accurate and reliable identity verification. Trust Stamp and Botdoc have a history of working together in various industries, including banking, lending, and insurance. Both companies are graduates of the Independent Community Bankers of America ThinkTECH accelerator. They have observed a growing trend of criminals using counterfeit or altered driver's licenses, driving permits, and ID cards to commit fraud. With nearly 80,000 cars stolen from dealerships in the past year, the need for robust identity document validation is more critical than ever. Through this partnership, Botdoc customers will be empowered to combat fraud more effectively. Trust Stamp’s low-code Orchestration Layer platform offers a variety of solutions, including the real-time capability to verify driver's license and ID information against data from the issuing agency. This feature significantly enhances the security and reliability of identity verification processes, helping businesses protect themselves and their customers from fraudulent activities. The integration of Trust Stamp’s advanced technology into Botdoc's Connect product represents a significant step forward in the fight against identity fraud. It underscores both companies' commitment to leveraging innovative solutions to address complex challenges in the digital age. Contact Details Proactive USA +1 347-449-0879 na-editorial@proactiveinvestors.com

July 26, 2024 10:22 AM Eastern Daylight Time

Video

1 ... 108 109 110 111 112 ... 3774